Susan Leslie Ireland
Known title: DirectorCIK: 0001718953
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
US presses China on Citigroup market access in Bangkok talks. The U.S. government has raised concerns about Citigroup's market access in China during bilateral talks in Bangkok. This diplomatic development highlights the ongoing regulatory and geopolitical risks associated with the bank's international operations. While Citi also initiated coverage on other companies like Mobileye, the trade discussions are the primary factor affecting the stock's broader outlook.
Transaction History
| AMTM | ▲ Buy | Grant | 5,062 | $0 | 2/6/2026 | View on chart |
| C | ▲ Buy | Grant | 16 | $1K | 4/1/2025 | View on chart |
| C | ▲ Buy | Grant | 158 | $11K | 4/1/2025 | View on chart |
| AMTM | ▲ Buy | Option Exercise | 3,447 | — | 3/5/2025 | View on chart |
| C | ▲ Buy | Grant | 136 | $10K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 2,118 | $0 | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 24 | $2K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 27 | $2K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 155 | $10K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 144 | $9K | 7/1/2024 | View on chart |
| C | ▲ Buy | Grant | 25 | $2K | 7/1/2024 | View on chart |
| C | ▲ Buy | Grant | 143 | $9K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 25 | $2K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 110 | $6K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 61 | $3K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 2,923 | $0 | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 137 | $6K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 75 | $3K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 115 | $5K | 7/1/2023 | View on chart |
| C | ▲ Buy | Grant | 63 | $3K | 7/1/2023 | View on chart |
| C | ▲ Buy | Grant | 115 | $5K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 63 | $3K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 3,353 | $0 | 1/3/2023 | View on chart |
| C | ▲ Buy | Grant | 86 | $4K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 54 | $2K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 79 | $4K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 49 | $2K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 77 | $4K | 7/1/2022 | View on chart |
| C | ▲ Buy | Grant | 48 | $2K | 7/1/2022 | View on chart |
| C | ▲ Buy | Grant | 68 | $4K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 22 | $1K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 2,255 | $0 | 2/10/2022 | View on chart |
| C | ▲ Buy | Grant | 44 | $3K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 36 | $2K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 39 | $3K | 10/1/2021 | View on chart |
| C | ▲ Buy | Grant | 32 | $2K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade
Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade. Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.